George Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil [Yahoo! Finance]
Bausch Health Companies Inc. (BHC)
Last bausch health companies inc. earnings: 2/19 06:59 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
medicines, including two doses that are lower than those currently available in single pill combinations, designed to deliver the blood pressure-lowering benefits of triple combination therapy early in the treatment pathway, with an established safety profile George Medicines receives upfront licensing fee and is eligible for regulatory and commercial milestone payments, as well as a future recurring revenue stream through a stepped royalty rate on sales in Brazil Third licensing agreement for GMRx2 follows deals with Bausch Health in Canada, Mexico, Colombia and Central America, and with Azurity Pharmaceuticals in the US London, UK, 2 October 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs in cardiometabolic disease, has entered into an exclusive licensing and supply agreement with Biolab Farmacêutica (“Biolab”), one of Brazil's largest pharmaceutical companies, granting Biolab exclusive rights to seek regulatory app
Show less
Read more
Impact Snapshot
Event Time:
BHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHC alerts
High impacting Bausch Health Companies Inc. news events
Weekly update
A roundup of the hottest topics
BHC
News
- Is There Now an Opportunity in Bausch Health Companies After Recent Debt Restructuring Developments? [Yahoo! Finance]Yahoo! Finance
- Bausch Health's Aesthetics Business, Solta Medical, Acquires Longtime Distribution Partner, the Shibo Group, to Strengthen Presence in China [Yahoo! Finance]Yahoo! Finance
- Bausch Health (NYSE:BHC) Valuation Update After OraPharma Expansion Into New Markets [Yahoo! Finance]Yahoo! Finance
- John Paulson's Strategic Move: Significant Increase in Bausch Health Companies Inc. [Yahoo! Finance]Yahoo! Finance
- Bausch Health Companies Inc. (BHC) Announces the Commercial Expansion of OraPharma into Canada and Puerto Rico [Yahoo! Finance]Yahoo! Finance
BHC
Earnings
- 10/29/25 - Miss
BHC
Sec Filings
- 11/28/25 - Form 4
- 11/24/25 - Form 8-K
- 11/14/25 - Form SCHEDULE
- BHC's page on the SEC website